{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:39:03Z","timestamp":1792787943290,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Sanming Project of Medicine in Shenzhen Nanshan","award":["SZSM202103003"],"award-info":[{"award-number":["SZSM202103003"]}]},{"name":"Major Scientific and Technological Project of the Health System in Nanshan Shenzhen","award":["NSZD2024062"],"award-info":[{"award-number":["NSZD2024062"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-025-02431-x","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T02:29:05Z","timestamp":1737080945000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["SRT3025-loaded cell membrane hybrid liposomes (3025@ML) enhanced anti-tumor activity of Oxaliplatin via inhibiting pyruvate kinase M2 and fatty acid synthase"],"prefix":"10.1186","volume":"24","author":[{"given":"Xiaobin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shulin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zichen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuona","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,17]]},"reference":[{"key":"2431_CR1","doi-asserted-by":"crossref","unstructured":"Jin YH, Zeng XT, Liu TZ, Bai ZM, Dou ZL, Ding DG, Fan ZL, Han P, Huang YR, Huang X et al. Treatment and surveillance for non-muscle-invasive bladder cancer: a clinical practice guideline (2021 edition). Mil Med Res 2022; 9;44.","DOI":"10.1186\/s40779-022-00406-y"},{"key":"2431_CR2","unstructured":"Anderson RL, Balasas T, Callaghan J, Coombes RC, Evans J, Hall JA, Kinrade S, Jones D, Jones PS, Jones R et al. A framework for the development of effective anti-metastatic agents. Nat Rev Clin Oncol 2019; 16185\u2013204."},{"key":"2431_CR3","doi-asserted-by":"crossref","unstructured":"Yang X, Zhang S, Cui Y, Li Y, Song X, Pang J. Efficacy and safety of transurethral resection of bladder tumour combined with chemotherapy and immunotherapy in bladder-sparing therapy in patients with T1 high-grade or T2 bladder cancer: a protocol for a randomized controlled trial. BMC Cancer 2023; 23;320.","DOI":"10.1186\/s12885-023-10798-2"},{"key":"2431_CR4","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/s41420-021-00665-z","volume":"7","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Chen X, Lin J, Jin X. Biological functions and clinical significance of long noncoding RNAs in bladder cancer. Cell Death Discov. 2021;7:278.","journal-title":"Cell Death Discov"},{"key":"2431_CR5","doi-asserted-by":"crossref","unstructured":"Linares J, Sallent-Aragay A, Badia-Ramentol J, Recort-Bascuas A, M\u00e9ndez A, Manero-Rup\u00e9rez N, Re DL, Rivas EI, Guiu M, Zwick M et al. Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy. Nat Commun 2023; 14;746.","DOI":"10.1038\/s41467-023-36334-1"},{"key":"2431_CR6","doi-asserted-by":"crossref","unstructured":"Jin H, He Y, Zhao P, Hu Y, Tao J, Chen J, Huang Y. Targeting lipid metabolism to overcome EMT-associated drug resistance via integrin \u03b23\/FAK pathway and tumor-associated macrophage repolarization using legumain-activatable delivery. Theranostics 2019; 9;265\u2013278.","DOI":"10.7150\/thno.27246"},{"key":"2431_CR7","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41392-024-01808-1","volume":"9","author":"Y Xia","year":"2024","unstructured":"Xia Y, Sun M, Huang H, Jin WL. Drug repurposing for cancer therapy. Signal Transduct Target Ther. 2024;9:92.","journal-title":"Signal Transduct Target Ther"},{"key":"2431_CR8","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.7150\/ijbs.27854","volume":"14","author":"Y Wang","year":"2018","unstructured":"Wang Y, Hao F, Nan Y, Qu L, Na W, Jia C, Chen X. PKM2 inhibitor shikonin overcomes the cisplatin resistance in bladder Cancer by inducing necroptosis. Int J Biol Sci. 2018;14:1883\u201391.","journal-title":"Int J Biol Sci"},{"key":"2431_CR9","doi-asserted-by":"publisher","first-page":"101758","DOI":"10.1016\/j.tranon.2023.101758","volume":"37","author":"MR Pandkar","year":"2023","unstructured":"Pandkar MR, Sinha S, Samaiya A, Shukla S. Oncometabolite lactate enhances breast cancer progression by orchestrating histone lactylation-dependent c-Myc expression. Transl Oncol. 2023;37:101758.","journal-title":"Transl Oncol"},{"key":"2431_CR10","first-page":"34","volume":"10","author":"YQ Li","year":"2023","unstructured":"Li YQ, Sun FZ, Li CX, Mo HN, Zhou YT, Lv D, Zhai JT, Qian HL, Ma F. RARRES2 regulates lipid metabolic reprogramming to mediate the development of brain metastasis in triple negative breast cancer. Mil Med Res. 2023;10:34.","journal-title":"Mil Med Res"},{"key":"2431_CR11","doi-asserted-by":"crossref","unstructured":"Luo P, Zhang Q, Zhong TY, Chen JY, Zhang JZ, Tian Y, Zheng LH, Yang F, Dai LY, Zou C et al. Celastrol mitigates inflammation in sepsis by inhibiting the PKM2-dependent Warburg effect. Mil Med Res 2022; 9;22.","DOI":"10.1186\/s40779-022-00381-4"},{"key":"2431_CR12","doi-asserted-by":"crossref","unstructured":"Wong N, De Melo J, Tang D. PKM2, a Central Point of Regulation in Cancer Metabolism. Int J Cell Biol 2013; 2013;242513.","DOI":"10.1155\/2013\/242513"},{"key":"2431_CR13","doi-asserted-by":"crossref","unstructured":"Gin\u00e9s A, Bystrup S, Ruiz de Porras V, Guardia C, Musul\u00e9n E, Mart\u00ednez-Card\u00fas A, Manzano JL, Layos L, Abad A, Mart\u00ednez-Balibrea E. PKM2 subcellular localization is involved in Oxaliplatin Resistance Acquisition in HT29 Human Colorectal Cancer Cell lines. PLoS ONE 2015; 10e0123830.","DOI":"10.1371\/journal.pone.0123830"},{"key":"2431_CR14","doi-asserted-by":"crossref","unstructured":"Chini CC, Espindola-Netto JM, Mondal G, Guerrico AM, Nin V, Escande C, Sola-Penna M, Zhang JS, Billadeau DD, Chini EN. SIRT1-Activating compounds (STAC) negatively regulate pancreatic Cancer cell growth and viability through a SIRT1 lysosomal-dependent pathway. Clin Cancer Res 2016; 222496\u20132507.","DOI":"10.1158\/1078-0432.CCR-15-1760"},{"key":"2431_CR15","doi-asserted-by":"crossref","unstructured":"Zhao S, Sun Y, Wu X, Yang Y, Fan K, Hu K, Qin Y, Li K, Lin L, Chen K et al. Sirtuin 1 activator alleviated lethal inflammatory injury via promotion of autophagic degradation of pyruvate kinase M2. Front Pharmacol 2023; 14;1092943.","DOI":"10.3389\/fphar.2023.1092943"},{"key":"2431_CR16","doi-asserted-by":"crossref","unstructured":"He B, Sui X, Yu B, Wang S, Shen Y, Cong H. Recent advances in drug delivery systems for enhancing drug penetration into tumors. Drug Deliv 2020; 271474\u20131490.","DOI":"10.1080\/10717544.2020.1831106"},{"key":"2431_CR17","doi-asserted-by":"crossref","unstructured":"Zhang W, Fan Y, Zhang J, Shi D, Yuan J, Ashrafizadeh M, Li W, Hu M, Abd El-Aty AM, Hacimuftuoglu A et al. Cell membrane-camouflaged bufalin targets NOD2 and overcomes multidrug resistance in pancreatic cancer. Drug Resist Updat 2023; 71;101005.","DOI":"10.1016\/j.drup.2023.101005"},{"key":"2431_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpb.2021.08.012","volume":"169","author":"W Zhang","year":"2021","unstructured":"Zhang W, Chen L, Cui M, Xie L, Xi Z, Wang Y, Shen X, Xu L. Successively triggered rod-shaped protocells for enhanced tumor chemo-photothermal therapy. Eur J Pharm Biopharm. 2021;169:1\u201311.","journal-title":"Eur J Pharm Biopharm"},{"key":"2431_CR19","doi-asserted-by":"crossref","unstructured":"Tomayko MM, Reynolds CP. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol 1989; 24;148\u2013154.","DOI":"10.1007\/BF00300234"},{"key":"2431_CR20","doi-asserted-by":"crossref","unstructured":"Liu Q, Zhang X, Qi J, Tian X, Dovjak E, Zhang J, Du H, Zhang N, Zhao J, Zhang Y et al. Comprehensive profiling of lipid metabolic reprogramming expands precision medicine for HCC. Hepatology : 2024.","DOI":"10.1097\/HEP.0000000000000962"},{"key":"2431_CR21","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ebiom.2018.12.037","volume":"40","author":"X Wang","year":"2019","unstructured":"Wang X, He S, Gu Y, Wang Q, Chu X, Jin M, Xu L, Wu Q, Zhou Q, Wang B, et al. Fatty acid receptor GPR120 promotes breast cancer chemoresistance by upregulating ABC transporters expression and fatty acid synthesis. EBioMedicine. 2019;40:251\u201362.","journal-title":"EBioMedicine"},{"key":"2431_CR22","doi-asserted-by":"crossref","unstructured":"Sardesai SD, Thomas A, Gallagher C, Lynce F, Ottaviano YL, Ballinger TJ, Schneider BP, Storniolo AM, Bauchle A, Althouse SK et al. Inhibiting fatty acid synthase with omeprazole to improve efficacy of Neoadjuvant Chemotherapy in patients with operable TNBC. Clin Cancer Res 2021; 275810\u20135817.","DOI":"10.1158\/1078-0432.CCR-21-0493"},{"key":"2431_CR23","doi-asserted-by":"crossref","unstructured":"Beher D, Wu J, Cumine S, Kim KW, Lu SC, Atangan L, Wang M. Resveratrol is not a direct activator of SIRT1 enzyme activity. Chem Biol Drug Des 2009; 74;619\u2013624.","DOI":"10.1111\/j.1747-0285.2009.00901.x"},{"key":"2431_CR24","doi-asserted-by":"crossref","unstructured":"Tang JC, An R, Jiang YQ, Yang J. Effects and mechanisms of Metformin on the proliferation of Esophageal Cancer cells in Vitro and in vivo. Cancer Res Treat 2017; 49778\u2013789.","DOI":"10.4143\/crt.2015.485"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02431-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-025-02431-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02431-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T02:29:29Z","timestamp":1737080969000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-025-02431-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,17]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2431"],"URL":"https:\/\/doi.org\/10.1186\/s12944-025-02431-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4691639\/v1","asserted-by":"object"}]},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,17]]},"assertion":[{"value":"5 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the Guangdong Medical Laboratory Animal Center Ethical Committee (Approval number: C202205-24 and D202410-5). All animal procedures were performed in accordance with the relevant ethical guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14"}}